Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Starting soon · Not applicable

Conditions studied: Chin Augmentation

In brief

The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.

Key facts

Study ID
NCT07566286
Run by
Galderma R&D
People needed
100
Starts
2026-06-03
Expected to finish
2028-02-28
Last updated by the study team
2026-07-01

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.